Molecularly targeted treatment of recurrent anaplastic astrocytoma – a case report

High‐grade astrocytomas are malignant and aggressive, with limited treatment options. Treatment is geared not only toward increasing patient’s overall survival but also in delaying or preventing neurological disability, a cause of significant morbidity. Increasingly, targeted and customized treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yalamanchi, Ashna, Gill, Jaya Mini, Truong, Judy, Nguyen, Minhdan, Carrillo, Jose, Wagle, Naveed, Sharma, Akanksha, Kesari, Santosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419407/
https://www.ncbi.nlm.nih.gov/pubmed/34328281
http://dx.doi.org/10.1002/acn3.51430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419407/
https://www.ncbi.nlm.nih.gov/pubmed/34328281
http://dx.doi.org/10.1002/acn3.51430

Ejemplares similares